Robert Alexander Ph.D.
Net Worth

Last updated:

What is Robert Alexander Ph.D. net worth?

The estimated net worth of Dr. Robert Alexander Ph.D. is at least $15,143,294 as of 4 Jun 2021. He owns shares worth $105,411 as insider, has earned $7,787,883 from insider trading and has received compensation worth at least $7,250,000 in Allakos Inc..

What is the salary of Robert Alexander Ph.D.?

Dr. Robert Alexander Ph.D. salary is $1,450,000 per year as Chief Executive Officer & Director in Allakos Inc..

How old is Robert Alexander Ph.D.?

Dr. Robert Alexander Ph.D. is 55 years old, born in 1970.

What stocks does Robert Alexander Ph.D. currently own?

As insider, Dr. Robert Alexander Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Allakos Inc. (ALLK) Chief Executive Officer & Director 320,300 $0.33 $105,411

What does Allakos Inc. do?

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

ALLK logo
ALLK
Allakos Inc.
$0.33

Robert Alexander Ph.D. insider trading

Allakos Inc.

Dr. Robert Alexander Ph.D. has made 14 insider trades between 2020-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 20,001 units of ALLK stock on 17 May 2021. As of 4 Jun 2021 he still owns at least 320,300 units of ALLK stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to buy) 14,516 $0.69 $9,987
Option
Common Stock 14,516 $0.69 $9,987
Sale
Common Stock 19,998 $45.16 $903,190
Sale
Common Stock 20,001 $47.62 $952,528
Option
Common Stock 14,517 $0.69 $9,988
Sale
Common Stock 20,001 $47.62 $952,528
Option
Stock Option (Right to buy) 14,517 $0.69 $9,988
Sale
Common Stock 20,001 $47.62 $952,528
Option
Stock Option (Right to buy) 14,517 $0.69 $9,988
Option
Common Stock 14,517 $0.69 $9,988
Sale
Common Stock 20,001 $47.62 $952,528
Option
Common Stock 14,516 $0.69 $9,987
Sale
Common Stock 14,516 $0.69 $9,987
Sale
Common Stock 19,998 $49.79 $995,680
Option
Stock Option (Right to buy) 14,516 $0.69 $9,987
Option
Stock Option (Right to buy) 14,517 $0.69 $9,988
Sale
Common Stock 20,001 $50.19 $1,003,830
Option
Common Stock 14,517 $0.69 $9,988
Sale
Common Stock 14,517 $0.69 $9,988
Sale
Common Stock 14,517 $0.69 $9,988
Option
Stock Option (Right to buy) 14,517 $0.69 $9,988
Option
Common Stock 14,517 $0.69 $9,988
Sale
Common Stock 20,001 $50.19 $1,003,830
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Sale
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 $0.69 $13,760
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 20,000 $0.69 $13,760
Option
Stock Option (Right to buy) 8,240 N/A N/A
Option
Common Stock 8,240 N/A N/A

Allakos key executives

Allakos Inc. executives and other stock owners filed with the SEC: